you are here: Home News Ranbaxy

Ranbaxy

Who makes a better suitor for Cipla and what is in it for shareholders?
Veterans Unpacked | D.S. Brar: "Your network is your net worth, and your credibility is your currency"
SC holds Singh brothers guilty of contempt in Daiichi Sankyo case
Delhi Police arrests former Ranbaxy promoter Shivinder Singh
Policy| Bottle of Lies: What ails India’s drug industry
SC asks ex-Ranbaxy promoters to apprise how they'll comply with Rs 3500 crore arbitral award
Opinion | Sun Pharma: New governance structure needed to protect investors' interest
NCLT dismisses HDFC plea for initiating insolvency proceedings against RHC Holding
A message for Indian pharma: Do what you say, say what you do
Analysts retain buy on Sun Pharma as USFDA clears Mohali, Halol unit resolution key
USFDA lifts import ban on Sun Pharma's Mohali plant, shares surge 5%
Sun Pharma soars 6% on US FDA’s plan to lift import alert at Mohali
Trump policies stressful for India pharma cos: Ex-Ranbaxy CEO
Daiichi to shut down Indian R&D centre; 170 employees impacted
Nifty on Cloud Nine! 9 stocks with a high margin of safety
COMMENT: Is Sun Pharma suffering on account of unrelated diversification?
Sun Pharma, Wockhardt in news on re-inspections, lawsuits
Positive on ITC & ICICI Bank, says Deven Choksey
Look at Sun Pharma, says Gaurang Shah
Making Ranbaxy units cGMP compliant time consuming: Sun Pharma
Continue to remain opportunistic for acquisitions: Sun Pharma
Sun Pharma falls 6% on weak sales guidance, price pressure woes
Sun Pharma, Daiichi terminate transaction pacts
More trouble for Ranbaxy as central regulator finds deficiencies
CCI okays PVR-DT Cinemas deal, asks to exclude certain assets

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Ranbaxy

Who makes a better suitor for Cipla and what is in it for shareholders?

Veterans Unpacked | D.S. Brar: "Your network is your net worth, and your credibility is your currency"

SC holds Singh brothers guilty of contempt in Daiichi Sankyo case

Delhi Police arrests former Ranbaxy promoter Shivinder Singh

Policy| Bottle of Lies: What ails India’s drug industry

SC asks ex-Ranbaxy promoters to apprise how they'll comply with Rs 3500 crore arbitral award

Opinion | Sun Pharma: New governance structure needed to protect investors' interest

NCLT dismisses HDFC plea for initiating insolvency proceedings against RHC Holding

A message for Indian pharma: Do what you say, say what you do

Analysts retain buy on Sun Pharma as USFDA clears Mohali, Halol unit resolution key

USFDA lifts import ban on Sun Pharma's Mohali plant, shares surge 5%

Sun Pharma soars 6% on US FDA’s plan to lift import alert at Mohali

Trump policies stressful for India pharma cos: Ex-Ranbaxy CEO

Daiichi to shut down Indian R&D centre; 170 employees impacted

Nifty on Cloud Nine! 9 stocks with a high margin of safety

COMMENT: Is Sun Pharma suffering on account of unrelated diversification?

Sun Pharma, Wockhardt in news on re-inspections, lawsuits

Positive on ITC & ICICI Bank, says Deven Choksey

Look at Sun Pharma, says Gaurang Shah

Making Ranbaxy units cGMP compliant time consuming: Sun Pharma

Continue to remain opportunistic for acquisitions: Sun Pharma

Sun Pharma falls 6% on weak sales guidance, price pressure woes

Sun Pharma, Daiichi terminate transaction pacts

More trouble for Ranbaxy as central regulator finds deficiencies

CCI okays PVR-DT Cinemas deal, asks to exclude certain assets